Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling

[1]  T. Kamiyama,et al.  CXCL12–CXCR7 axis is important for tumor endothelial cell angiogenic property , 2015, International journal of cancer.

[2]  K. Walter,et al.  Chemokine Receptor CXCR7 Is a Functional Receptor for CXCL12 in Brain Endothelial Cells , 2014, PloS one.

[3]  T. Schall,et al.  Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels , 2014, Immunology.

[4]  C. Hsieh,et al.  Molecular Imaging of Heparan Sulfate Expression with Radiolabeled Recombinant Eosinophil Cationic Protein Predicts Allergic Lung Inflammation in a Mouse Model for Asthma , 2013, The Journal of Nuclear Medicine.

[5]  M. Hung,et al.  Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke , 2013, EMBO molecular medicine.

[6]  Y. Yu,et al.  Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 , 2013, Leukemia.

[7]  C. Hsieh,et al.  Imaging the Impact of Nox4 in Cycling Hypoxia-mediated U87 Glioblastoma Invasion and Infiltration , 2012, Molecular Imaging and Biology.

[8]  J. Hare,et al.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.

[9]  Mukesh K. Jain,et al.  Endothelial differentiation: molecular mechanisms of specification and heterogeneity. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[10]  S. Cai,et al.  The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells , 2011, Journal of cellular and molecular medicine.

[11]  M. Ratajczak,et al.  CXCR7: a new SDF‐1‐binding receptor in contrast to normal CD34+ progenitors is functional and is expressed at higher level in human malignant hematopoietic cells , 2010, European journal of haematology.

[12]  P. Oettgen,et al.  Molecular mechanisms of endothelial differentiation , 2010, Vascular medicine.

[13]  T. Kume.  Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. , 2010, Histology and histopathology.

[14]  Yubo Fan,et al.  Endothelium oriented differentiation of bone marrow mesenchymal stem cells under chemical and mechanical stimulations. , 2010, Journal of biomechanics.

[15]  T. Tian,et al.  Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells , 2010, Journal of experimental & clinical cancer research : CR.

[16]  M. Studer,et al.  The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. , 2010, Genes & development.

[17]  B. Adams.  Faculty Opinions recommendation of Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. , 2010 .

[18]  U. Naumann,et al.  CXCR7 Functions as a Scavenger for CXCL12 and CXCL11 , 2010, PloS one.

[19]  Mahesh Choolani,et al.  Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. , 2010, Biomaterials.

[20]  R. Lefkowitz,et al.  β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 , 2009, Proceedings of the National Academy of Sciences.

[21]  Lei Zhang,et al.  Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  B. Weinstein,et al.  Arterial–Venous Specification During Development , 2009, Circulation research.

[23]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[24]  Prashant Mali,et al.  Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. , 2008, Cell stem cell.

[25]  D. S. van Ingen Schenau,et al.  Early postnatal lethality and cardiovascular defects in CXCR7‐deficient mice , 2008, Genesis.

[26]  Erez Raz,et al.  Control of Chemokine-Guided Cell Migration by Ligand Sequestration , 2008, Cell.

[27]  C. Hsieh,et al.  Generation of Destabilized Herpes Simplex Virus Type 1 Thymidine Kinase as Transcription Reporter for PET Reporter Systems in Molecular–Genetic Imaging , 2007, Journal of Nuclear Medicine.

[28]  Alnawaz Rehemtulla,et al.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature , 2007, Proceedings of the National Academy of Sciences.

[29]  C. Kielty,et al.  Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors , 2007, Journal of cellular and molecular medicine.

[30]  M. Iruela-Arispe,et al.  Notch signaling in blood vessels: who is talking to whom about what? , 2007, Circulation research.

[31]  C. Kielty,et al.  Vascular endothelial growth factor can signal through platelet-derived growth factor receptors , 2007, The Journal of cell biology.

[32]  L. Claesson‐Welsh,et al.  Platelet-derived growth factor receptor- promotes early endothelial cell differentiation , 2006 .

[33]  Kevin Wei,et al.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.

[34]  Randy L. Johnson,et al.  Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. , 2005, Developmental biology.

[35]  W. Vaughn,et al.  Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model , 2005, Circulation.

[36]  Gerhard Ehninger,et al.  Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.

[37]  Manfred Gessler,et al.  The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. , 2004, Genes & development.

[38]  Tomoki Aoyama,et al.  Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. , 2002, Biochemical and biophysical research communications.

[39]  M. Fishman,et al.  Gridlock signalling pathway fashions the first embryonic artery , 2001, Nature.

[40]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[41]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[42]  D. Housman,et al.  Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1 , 1998, Immunogenetics.

[43]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[44]  S. Kourembanas,et al.  Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. , 1995, Circulation research.

[45]  C. Cabañas,et al.  CXCR7 impact on CXCL12 biology and disease. , 2013, Trends in molecular medicine.

[46]  Hans Michael Piper,et al.  Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. , 2009, Cardiovascular research.

[47]  M. Soleimani,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow , 2009, Nature Protocols.